Use of proton pump inhibitors in general practice

doi:10.4292/wjgpt.v8.i3.180

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13633)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

964

WORD

285

HTML

5578

Figures (1-1)

577

Tables (1-3)

496

Sum=7900

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

1033

Download

1711

Sum=2744

Publishing Process of This Article

Item

Count

Browse

1178

Download

1801

Sum=2979

Aug 6, 2017 (publication date) through Feb 17, 2026

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Study

World J Gastrointest Pharmacol Ther. Aug 6, 2017; 8(3): 180-185
Published online Aug 6, 2017. doi: 10.4292/wjgpt.v8.i3.180

Use of proton pump inhibitors in general practice

Cesare Tosetti, Ilaria Nanni

Cesare Tosetti, Ilaria Nanni, Health Agency of Bologna, 40046 Alto Reno Terme, Italy

Author contributions: Tosetti C and Nanni I contributed equally in the study design, literature reviewing and data evaluation; Tosetti C wrote the paper with the critical contribution of Nanni I.

Conflict-of-interest statement: No financial relationships to disclose.

Data sharing statement: No additional data are available.

Correspondence to: Cesare Tosetti, MD, General Practitioner, Health Agency of Bologna, Via Rosselli 21, Porretta Terme, 40046 Alto Reno Terme, Italy. tosetti@libero.it

Telephone: +39-338-3902526 Fax: +39-534-21493

Received: December 28, 2016
Peer-review started: December 29, 2016
First decision: March 13, 2017
Revised: April 18, 2017
Accepted: July 14, 2017
Article in press: July 17, 2017
Published online: August 6, 2017
Processing time: 215 Days and 0.7 Hours

Core Tip

Core tip: This study was carried out in a large unselected population to evaluate the characteristics of proton pump inhibitor (PPI) prescription and the adherence to the guidelines regulating the reimbursement limitations set forth by the Italian Drug Agency. A substantial number of patients who apparently do not meet prescription suitability conditions can be identified, but among non-PPI users on the contrary, it is possible to identify an equal number of patients for whom prescription would be suitable. According to our data the greatest problems in clinical decision originate in patients in antithrombotic therapy.